Clinical significance of microvessel density in multiple myeloma patients

被引:17
作者
Ahn, MH
Park, CK
Choi, JH
Lee, WM
Lee, YY
Choi, IY
Kim, IS
Lee, WS
Ki, M
机构
[1] Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[2] Hanyang Univ, Coll Med, Dept Pathol, Seoul, South Korea
[3] Hanyang Univ, Coll Med, Dept Clin Pathol, Seoul, South Korea
[4] Eul Ji Univ, Sch Med, Dept Prevent Med, Taejon, South Korea
关键词
microvessel density; multiple myeloma; survival;
D O I
10.3346/jkms.2001.16.1.45
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To investigate the role of angiogenesis in multiple myeloma (MM), bone marrow biopsy from 75 adults with newly diagnosed, untreated MM were evaluated. Microvessels were scored in at least 3 areas (x200 fields) of the highest microvessel density in representative sections of each bone marrow specimen using immunohistochemistry for CD34, Prognostic variables were also evaluated for the overall survival, Microvessel counts were significantly higher in patients with MM (n=69.42+/-9.67), compared with control (n=26.81+/-2.85). Microvessel density had a weak correlation with percentage of bone marrow plasma cells, By univariate analysis, age, beta2-microglobulin, serum albumin, serum creatinine, serum calcium, hemoglobin, platelet count, and bone marrow plasma cell percentage were correlated with survival. By multivariate analysis, age, serum albumin, serum creatinine, hemoglobin, platelet count and bone marrow plasma cell percentage were correlated with overall survival, whereas microvessel density was not. In summary, microvessel density in bone marrow of MM is significantly increased compared to control, but was not correlated with overall survival. Further studies regarding angiogeneic molecules are needed to determine the functional role of angiogenesis in MM.
引用
收藏
页码:45 / 50
页数:6
相关论文
共 24 条
[1]   Vascular enumeration as a significant prognosticator for invasive breast carcinoma [J].
Aceñero, MJF ;
González, JF ;
Gallego, MG ;
Ballesteros, PA .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) :1684-1688
[2]   Metalloproteinases in multiple myeloma: Production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells [J].
Barille, S ;
Akhoundi, C ;
Collette, M ;
Mellerin, MP ;
Rapp, MJ ;
Harousseau, JL ;
Bataille, R ;
Amiot, M .
BLOOD, 1997, 90 (04) :1649-1655
[3]   Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma [J].
Dankbar, B ;
Padró, T ;
Leo, R ;
Feldmann, B ;
Kropff, M ;
Mesters, RM ;
Serve, H ;
Berdel, WE ;
Kienast, J .
BLOOD, 2000, 95 (08) :2630-2636
[4]   QUANTIFICATION OF ANGIOGENESIS AS AN INDEPENDENT PREDICTOR OF PROGNOSIS IN INVASIVE BLADDER CARCINOMAS [J].
DICKINSON, AJ ;
FOX, SB ;
PERSAD, RA ;
HOLLYER, J ;
SIBLEY, GNA ;
HARRIS, AL .
BRITISH JOURNAL OF UROLOGY, 1994, 74 (06) :762-766
[5]  
DURIE BGM, 1977, RECENT ADV HAEMATOLO, P243
[6]   ANGIOGENESIS AND BREAST-CANCER METASTASIS [J].
ELLIS, LM ;
FIDLER, IJ .
LANCET, 1995, 346 (8972) :388-390
[7]   New perspectives in clinical oncology from angiogenesis research [J].
Folkman, J .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (14) :2534-2539
[8]   Seminars in medicine of the Beth Israel Hospital, Boston - Clinical applications of research on angiogenesis [J].
Folkman, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (26) :1757-1763
[9]   Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: A prospective study [J].
Fontanini, G ;
Lucchi, M ;
Vignati, S ;
Mussi, A ;
Ciardiello, F ;
DeLaurentiis, M ;
DePlacido, S ;
Basolo, F ;
Angeletti, CA ;
Bevilacqua, G .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (12) :881-886
[10]   Tumour angiogenesis and prognosis [J].
Fox, SB .
HISTOPATHOLOGY, 1997, 30 (03) :294-301